Financials

Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25

Definium Therapeutics Inc

Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.